Comparisons of ATPIII [−] PCOS patients (N = 209) and ATPIII [−] controls (N = 96), who shared similar anthropometric characteristics, showed major differences between these two subcohorts were levels of LH, testosterone, fasting and stimulated insulin, fasting and stimulated C-peptide, and AUC(insulin) as well as the F-M score (Table S3). The gene discussed is PLOD1; the disease is polycystic ovary syndrome.